is oral semaglutide as effective as injection Day 5: Rybelsus (Oral Semaglutide) Class: GLP-1 receptor agonist Avg Weight Loss: 5–10% FDA Approved: 2019 for T2DM; being studied for obesity Pros: First GLP-1 agonist Non-injection option for blood What to Know About Semaglutide:

Remember: damage can be invisible Potency can drop well before anything looks wrong

doi: 10.1016/j.cellsig.2018.10.005 6

the regulatory approval process of the FDA and comparable foreign regulatory authorities is lengthy, time-consuming and inherently unpredictable, and even if we complete the necessary clinical studies, we cannot predict when, or if, we will obtain regulatory approval or certification for any of our product candidates, and any such regulatory approval or certification may be for a more narrow indication than we seek

Genes Chromosomes Cancer 48 , 261271 (2009)

W.HellerstedtW

Patients allergic to tirzepatide, with a history of medullary thyroid cancer, MEN 2 syndrome, pregnant and breastfeeding females, and children should not use tirzepatide